fda statement bpc-157 not approved for human use Wolverine Stack: Healing Faster with Peptides Which non-FDA (United States Food

Hypersensitivity has been observed at the injection site in longer-term clinical trials, with repeated injections carried out on patients with neuropathy, for example, diabetic polyneuropathy (40)

Arif, H., & Aggarwal, S

What this means for you right now: BPC-157 and TB-500 are currently available through licensed compounding pharmacies under clinician supervision Thymosin Alpha-1 has a longer regulatory history and a more established compounding track record Sourcing from unregulated vendors carries real safety risks contamination, misdosing, and no quality control We've covered the full regulatory picture in detail here: PCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1 What a Clinician-Supervised Long COVID Peptide Protocol Looks Like A responsible protocol starts with assessment not assumption

Researcher Note: Always reconstitute and store your peptides in separate vials